Inventor · disambiguated record
Helen Usansky
Also filed as: USANSKY HELEN · USANSKY HELEN H · USANSKY HELEN HUI
4 granted patents·5 pending applications·54 citations·filing 2000–2024
70Inventor score
Top patents by PatentIndex Score
9 records- 0189US6395787B1Ocular hypotensive lipidsALLERGAN SALES INC·Filed 2000·Granted May 28, 2002·51 cites·34 claims
- 0269US12036224B2Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredientLIBERTAS BIO INC·Filed 2023·Granted Jul 16, 2024·0 cites·26 claims
- 0369US2024307398A1Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredientLIBERTAS BIO INC·Filed 2024·Application pending·0 cites
- 0466US8778413B2Dosing regimens and methods of treatment using carbon monoxideUSANSKY HELEN H·Filed 2011·Granted Jul 15, 2014·3 cites·5 claims
- 0555US2024226112A1Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating cystic fibrosisINSMED INC·Filed 2022·Application pending·0 cites
- 0651US2019008868A1Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredientASANA BIOSCIENCES LLC·Filed 2018·Application pending·0 cites
- 0749US2023027072A1Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of erk1 and erk2ASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 0846US10695296B2Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredientASANA BIOSCIENCES LLC·Filed 2018·Granted Jun 30, 2020·0 cites·28 claims
- 0941US2014287066A1Dosing regimens and methods of treatment using carbon monoxideUSANSKY HELEN H·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Helen Usansky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →